Hims & Hers Stock Jumps 54% as Novo Nordisk Truce Ends Legal Dispute Over Ozempic Alternatives | MarketWire

Hims & Hers shares soared 54% after resolving a legal fight with Novo Nordisk, impacting the telehealth and pharma sectors.